06.12.2022 - 08.12.2022Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 09:00 - 16:00
Conference themes With no room for error in the highly competitive ADC market and no going back after you have selected your target, it is vital that drug developers optimally triangulate the linker-payload, target and indication to develop an ADC that can have the biggest impact on patients.
Recent exciting developments in linker-payload technologies and clinical efficacy in low-expressed tumors have propelled this conversation to the forefront of mind.